CI

At a glance

ClinicalIndex Comparison Record
N/AWithdrawn· 0 enrolled
Drug / intervention
Sleeping Disturbancesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05044312
NCT05044312N/AWithdrawn
Withdrawn

Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

M.D. Anderson Cancer Center·interventional·Posted Sep 14, 2021·Updated Jan 23, 2026

In Brief

A clinical study evaluating Sleeping Disturbances for GI Cancers and Gastrointestinal Cancer. Withdrawn before enrollment.

Signals

Trial was withdrawn before enrollment

Detailed Summary

The primary objective of the study is to determine sleep disturbance and its types among patients with gastrointestinal cancers during the perioperative period (preoperative and in-hospital stay following surgery) by using Richard Campbell sleep questionnaire (RCSQ). The primary objective of this study is to determine the SD during preoperative and post-operative periods evaluated by Richard Campbell Sleep questionnaire. Patients will be asked every 24 hours while at the hospital (before and after surgery) to fill out this questionnaire. The mean RCSQ score at each time point (i.e., before and after surgery) will be calculated for each patient. The overall mean (across all patients) will be calculated and reported along a 95% CI.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/AWithdrawnFinished
202120222023202420252026
First PostedSep 14, 2021
Enrollment StartMar 6, 2020
Primary CompletionJan 15, 2026
TodayJul 1, 2026
Enrollment to primary: 5.9 yearsPosted 4.8 years ago

Interventions

Sleeping Disturbancesother

most common complaints of patients after surgery and may affect the ability to carry out daily activities, quality of life, and post-surgery recovery.